Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancer.

MLA

Duchesneau, Emilie D., et al. “Longitudinal Trajectories of a Claims-Based Frailty Measure during Adjuvant Chemotherapy in Women with Stage I-III Breast Cancer.” Oncologist, vol. 29, no. 10, Oct. 2024, pp. e1291–301. EBSCOhost, https://doi.org/10.1093/oncolo/oyae092.

APA

Duchesneau, E. D., Reeder-Hayes, K., Stürmer, T., Kim, D. H., Edwards, J. K., & Lund, J. L. (2024). Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancer. Oncologist, 29(10), e1291–e1301. https://doi.org/10.1093/oncolo/oyae092

Chicago

Duchesneau, Emilie D, Katherine Reeder-Hayes, Til Stürmer, Dae Hyun Kim, Jessie K Edwards, and Jennifer L Lund. 2024. “Longitudinal Trajectories of a Claims-Based Frailty Measure during Adjuvant Chemotherapy in Women with Stage I-III Breast Cancer.” Oncologist 29 (10): e1291–1301. doi:10.1093/oncolo/oyae092.